The Top 15 U.S. Manufacturing Investments of 2025

From tech giants building mega chip fabs to automakers shifting more vehicle production back to the U.S., and pharma companies adding new plants, 2025 looks like a blockbuster year for manufacturing announcements.

These aren’t just billion-dollar headlines — they’re supply chain game-changers, fueled by tariff pressure and a White House drive to bring manufacturing home. President Trump’s steep tariffs on cars, steel, and semiconductors, combined with stricter sourcing rules, have made offshore production costlier and less predictable. Companies are responding by reshoring operations to avoid tariffs, secure supply chains, and gain political goodwill.

The result is a nationwide surge in factory building that could reshape where products are made and how they move. Here are 15 of the biggest investments of 2025 so far, and what they mean for jobs, innovation, and America’s industrial base.

Apple has announced a massive $100 billion addition recently to its U.S. manufacturing commitment, bringing the total to $600 billion over four years. This funding covers a range of projects: from glass production with Corning in Kentucky, to wafer sourcing in Texas, to expanded chip and component assembly.

Apple is also scaling its in-house silicon engineering and partnering with U.S. suppliers for precision manufacturing. The goal is clear—bring more of its production stateside to reduce reliance on overseas suppliers and shorten lead times. Thousands of new jobs are expected, particularly in advanced manufacturing and materials science. For U.S. supply chains, this strengthens domestic resilience in electronics, semiconductors, and optics.

Taiwan Semiconductor Manufacturing Company (TSMC) is going all-in on U.S. production, adding $100 billion to its Arizona investments, raising the total to $165 billion. This expansion includes cutting-edge fabrication plants, advanced packaging lines, and a large R&D hub near Phoenix. It’s the biggest single foreign direct investment in U.S. history.

TSMC’s chips power everything—from smartphones to AI servers—and having advanced nodes made in America reduces dependence on Asia for critical tech. Construction will create tens of thousands of jobs, while supplier networks for chemicals, gases, and specialized equipment will grow around the site. The move also aligns with the U.S. push to secure semiconductor supply after years of shortages. For manufacturers and consumers, this could mean faster delivery of high-end chips and less risk of production halts due to overseas disruptions.

Micron is nearly doubling its U.S. investment to $200 billion, aimed at producing more high-performance memory chips at home. New fabs are coming to Idaho, with expansions in Virginia, plus potential mega-fabs in New York. Micron will also boost its domestic R&D to speed up innovation in high-bandwidth memory and advanced packaging—key technologies for AI, electric vehicles, and cloud computing.

The company says these projects will create thousands of jobs over the next decade, spanning engineers, technicians, and supply chain roles. By making more memory chips in the U.S., Micron reduces America’s vulnerability to overseas bottlenecks, particularly in Asia. This is a big win for sectors like automotive and data centers, where memory shortages have slowed production. Expect ripple effects across suppliers of chemicals, wafers, and manufacturing tools nationwide.

IBM is investing $150 billion over the next five years to strengthen its U.S. manufacturing and innovation capabilities. This covers new tech facilities, expanded R&D labs, and in-house production for critical hardware that supports enterprise computing and AI workloads.

Part of the plan includes modernizing IBM’s chip packaging operations, increasing production of mainframes, and improving cloud infrastructure hardware. The investment also supports collaboration with U.S. universities for advanced semiconductor research.

For the manufacturing sector, IBM’s push will create demand for domestic suppliers of high-precision parts, circuit boards, and advanced materials. This expansion comes at a time when AI computing power needs are skyrocketing, and businesses want more secure, locally produced systems.

Johnson & Johnson is committing $55 billion to expand its U.S.-based manufacturing, research, and technology capabilities. The plan includes new pharmaceutical production facilities, upgrades to medical device manufacturing, and expanded consumer health product lines.

These investments will create thousands of jobs, particularly in high-skill areas like biologics manufacturing and quality control. By scaling operations in the U.S., J&J aims to reduce supply chain risks that became evident during the pandemic, when overseas disruptions delayed key medical products.

Domestic production also means faster response times for emerging health needs and better coordination with U.S. regulators. Beyond health products, the expansion will have a spillover effect on suppliers of packaging, raw materials, and specialized equipment. It’s a signal that major healthcare manufacturers are serious about building secure, responsive supply chains closer to home.

Swiss healthcare giant Roche is investing $50 billion to expand its U.S. manufacturing and R&D footprint. This includes new facilities for diagnostics, biologics, and personalized medicine production.

The company plans to strengthen its supply of high-demand cancer treatments and critical testing kits, ensuring faster delivery to U.S. hospitals and clinics. The expansion will also include advanced automation technologies, boosting productivity and reducing manufacturing lead times.

With a focus on biologics, Roche will rely heavily on domestic suppliers for bioprocessing equipment, sterile packaging, and raw materials. This move supports not only patient access but also U.S. job creation in pharma manufacturing, biotech engineering, and clinical research.

Bristol Myers Squibb (BMS) has unveiled a $40 billion plan to upgrade and expand its U.S. manufacturing capabilities over the next five years. This includes building new plants for biologic drugs, expanding existing pharmaceutical production lines, and modernizing facilities with advanced automation.

The company is also investing in supply chain resilience, ensuring faster distribution of treatments for cancer, cardiovascular disease, and immune disorders. By expanding domestically, BMS aims to shorten production cycles, reduce dependency on overseas suppliers, and meet growing demand for specialty drugs in the U.S. The investment will generate thousands of jobs, ranging from scientists and engineers to manufacturing technicians. For American supply chains, this means more stability in critical healthcare segments and a boost to local suppliers of biotech materials, lab equipment, and packaging solutions.

Eli Lilly is pledging $50 billion to strengthen U.S. pharmaceutical manufacturing, with a focus on building four new production sites. Three will be dedicated to active pharmaceutical ingredients (APIs) and one to sterile injectables, including treatments for diabetes and obesity.

These facilities will use state-of-the-art technology to improve efficiency, increase output, and ensure consistent quality. By expanding its U.S. footprint, Eli Lilly is aiming to secure its supply chain for critical medicines, reduce lead times, and mitigate risks from international disruptions. The company also expects significant job growth, from manufacturing operators to quality assurance specialists. This investment aligns with a wider push by the pharmaceutical industry to bring essential drug production closer to U.S. markets, enhancing both patient access and national healthcare security in the process.

Hyundai Motor Group is rolling out a $21 billion investment in the U.S., spanning automotive, EV, and steel manufacturing. A major highlight is the $5.8 billion steel plant in Louisiana, designed to supply high-strength steel for vehicles made in America. Hyundai is also expanding EV assembly capacity, battery production, and component manufacturing in Georgia and nearby states.

The strategy strengthens the Southeast’s role as a key automotive corridor, with new supply opportunities for local parts makers, logistics providers, and construction firms. By producing more vehicles and components in the U.S., Hyundai aims to reduce shipping costs, cut delivery times, and respond faster to changing consumer demand. The investment will create thousands of jobs in engineering, assembly, and materials processing, boosting regional economies while securing supply chains.

John Deere is committing $20 billion over the next decade to modernize and expand its U.S. operations. The plan includes upgrading plants to produce next-generation combines, tractors, and AI-enabled sprayers. Deere will integrate advanced manufacturing techniques like robotics, precision machining, and connected equipment monitoring.

The investment is aimed at boosting production capacity, shortening delivery times, and keeping up with global demand for agricultural machinery. For U.S. farmers, this means faster access to equipment and improved service support. For suppliers, it’s a steady demand for castings, hydraulics, sensors, and software. This long-term commitment also positions Deere to lead in smart agriculture, where automation and data are becoming as important as horsepower. It’s a clear bet on America’s agricultural heartland and the industries that keep it running.

General Motors is investing $4 billion to shift more vehicle production from Mexico to the U.S., focusing on plants in Michigan, Kansas, and Tennessee. The plan includes upgrading assembly lines, adding flexible manufacturing systems, and preparing facilities for new EV and hybrid models.

By moving production closer to its largest market, GM will shorten supply lines, reduce logistics costs, and improve responsiveness to customer demand. The investment will create thousands of manufacturing jobs and stimulate local supplier networks for parts, materials, and services. It’s also a strategic move to align with policies favoring domestic auto manufacturing and to strengthen resilience against international trade disruptions.

Kraft Heinz is making its largest U.S. factory investment in decades — $3 billion to modernize facilities across the country. The upgrades will add new automation, expand production lines, and improve energy efficiency in plants, making everything from ketchup to macaroni and cheese.

By investing in domestic capacity, Kraft Heinz aims to meet growing demand faster, reduce reliance on imports, and improve food safety oversight. The plan will create hundreds of jobs and boost orders for U.S. suppliers of ingredients, packaging, and food-processing equipment. For the American food manufacturing sector, it’s a major vote of confidence in keeping production close to the consumer.

LG Energy Solution is building a $5.5 billion battery manufacturing complex in Queen Creek, Arizona. The site will have two plants: one for EV batteries and another for energy storage systems. This will be one of North America’s largest battery hubs, supplying automakers and renewable energy projects. LG plans to source more raw materials from the U.S. and allied suppliers, reducing dependency on Chinese components. Thousands of jobs will be created, and Arizona will solidify its role as a key EV supply chain center. For U.S. manufacturing, this is a critical step in scaling domestic battery production to meet surging demand in transportation and energy storage.

GE Aerospace will invest nearly $1 billion to modernize factories making jet engines and aircraft components. The upgrades will expand machining capacity, improve additive manufacturing processes, and increase output for commercial and military programs. With air travel demand surging and defense orders climbing, these improvements will help GE meet delivery schedules without bottlenecks.

The investment will strengthen domestic supply chains for aerospace castings, forgings, and precision components, reducing reliance on foreign sources. Thousands of jobs will be supported in engineering, operations, and supplier networks. For U.S. aviation, this is a timely boost to capacity and competitiveness.

Tariff pressures are a big driver: higher U.S. import tariffs on cars, chips, and other goods have increased the costs and risks of offshore production. To avoid those tariffs and stabilize supply chains, many firms are reshoring or expanding domestic plants.

The Trump administration’s tariffs and stricter sourcing rules make importing goods more expensive, nudging companies to produce in the U.S. This is especially true for high-value items like electronics and pharmaceuticals. Many firms, including Apple, Roche, and Gilead, point directly to tariff threats and shifting trade policies as key reasons for boosting domestic production.

While some announcements build on previous long-term strategies, there’s a noticeable acceleration in 2025 tied directly to the current political climate and trade incentives. Critics note that some companies are reframing existing plans to align with the “manufacturing comeback” narrative, but most investments still represent significant near-term capital outlays.

Manufacturing still plays a powerful role in the U.S. economy. According to the National Association of Manufacturers (NAM), in Q1 2025, it contributed nearly $2.9 trillion—about 9.7% of GDP. For every dollar spent in manufacturing, there's a ripple effect of $2.64 across the economy. Plus, for every job in manufacturing, nearly 5 more jobs are created in related sectors.

Not yet. The U.S. currently faces several hundred thousand open manufacturing jobs — estimates project nearly 2 million could go unfilled by 2033 due to skills gaps. Without major investments in training and upskilling, this talent shortage could stall the growth that companies are banking on.